Found: 25
Select item for more details and to access through your institution.
Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 429, doi. 10.1007/s10549-022-06581-9
- By:
- Publication type:
- Article
HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 523, doi. 10.1007/s10549-022-06578-4
- By:
- Publication type:
- Article
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 437, doi. 10.1007/s10549-022-06585-5
- By:
- Publication type:
- Article
The clinical impact of MRI on surgical planning for patients with in-breast tumor recurrence.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 515, doi. 10.1007/s10549-022-06589-1
- By:
- Publication type:
- Article
PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 349, doi. 10.1007/s10549-022-06570-y
- By:
- Publication type:
- Article
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 417, doi. 10.1007/s10549-022-06577-5
- By:
- Publication type:
- Article
Trajectories of objectively measured physical function among older breast cancer survivors in comparison with cancer-free controls.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 467, doi. 10.1007/s10549-022-06568-6
- By:
- Publication type:
- Article
Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 361, doi. 10.1007/s10549-022-06567-7
- By:
- Publication type:
- Article
Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 495, doi. 10.1007/s10549-022-06571-x
- By:
- Publication type:
- Article
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 319, doi. 10.1007/s10549-022-06537-z
- By:
- Publication type:
- Article
Clinical trial data and emerging strategies: HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 281, doi. 10.1007/s10549-022-06575-7
- By:
- Publication type:
- Article
Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 477, doi. 10.1007/s10549-022-06573-9
- By:
- Publication type:
- Article
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 253, doi. 10.1007/s10549-022-06572-w
- By:
- Publication type:
- Article
Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 393, doi. 10.1007/s10549-022-06565-9
- By:
- Publication type:
- Article
Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 265, doi. 10.1007/s10549-022-06533-3
- By:
- Publication type:
- Article
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 331, doi. 10.1007/s10549-022-06569-5
- By:
- Publication type:
- Article
Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 445, doi. 10.1007/s10549-022-06564-w
- By:
- Publication type:
- Article
Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 381, doi. 10.1007/s10549-022-06559-7
- By:
- Publication type:
- Article
Safe perioperative tamoxifen use in autologous breast free flap reconstruction: systematic review and meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 241, doi. 10.1007/s10549-022-06558-8
- By:
- Publication type:
- Article
Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 293, doi. 10.1007/s10549-022-06549-9
- By:
- Publication type:
- Article
Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 455, doi. 10.1007/s10549-022-06563-x
- By:
- Publication type:
- Article
Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 485, doi. 10.1007/s10549-022-06560-0
- By:
- Publication type:
- Article
B7 homolog 3 induces lung metastasis of breast cancer through Raf/MEK/ERK axis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 405, doi. 10.1007/s10549-022-06520-8
- By:
- Publication type:
- Article
PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 305, doi. 10.1007/s10549-021-06501-3
- By:
- Publication type:
- Article
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 507, doi. 10.1007/s10549-021-06498-9
- By:
- Publication type:
- Article